Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award
MD, FRCPC at Mount Sinai Hospital, Canada
Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.
Professional Profile
Education
Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.
Professional Experience
Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.
Research Interest
Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.
Award and Honor
Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.
Research Skill
Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.
Conclusion
Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.
Publications Top Noted
-
Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
Cited by: 548 -
Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
Cited by: 105 -
Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
Cited by: 52 -
Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
Cited by: 23 -
Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
Cited by: 19 -
Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
Cited by: 6 -
Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
Cited by: 3 -
Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
Cited by: 2